Tuesday, 14 January 2020

NHS to trial twice-yearly injection alternative to statins

NHS to trial twice-yearly injection alternative to statins Mass trial of drug inclisiran comes after health service strikes deal with Novartis

The NHS is to launch a mass trial of an as-yet unapproved twice-yearly cholesterol-lowering injection, which it hopes will save lives and cut medical bills for thousands of people who do not take statins.

About 40,000 people with high “bad” or low-density lipoprotein cholesterol will be invited to join the trial of inclisiran by NHS England via their GPs. The NHS has struck a novel deal with drugmaker Novartis, which will provide the injections free in exchange for the results of the five-year trial, which will be run by the NHS staff. The Guardian

See also:

No comments:

Post a Comment